Implementation of patient dosimetry in the clinical practice after targeted radiotherapy using [177Lu-[DOTA0, Tyr3]-octreotate

Implementation of patient dosimetry in the clinical practice after targeted radiotherapy using [177Lu-[DOTA0, Tyr3]-octreotate

Abstract Background This study’s aim was to develop our dosimetric methodology using a commercial workstation for the routine evaluation of the organs at risk during peptide receptor radionuclide therapy (PRRT) with 177Lu. Methods First, planar and SPECT sensitivity factors were determined on phanto...

Full description

Bibliographic Details
Main Authors: Lore Santoro, Erick Mora-Ramirez, Dorian Trauchessec, Soufiane Chouaf, Pierre Eustache, Jean-Pierre Pouget, Pierre-Olivier Kotzki, Manuel Bardiès, Emmanuel Deshayes
Format: Article
Language:English
Published: SpringerOpen 2018-11-01
Series:EJNMMI Research
Subjects:
Peptide receptor radionuclide therapy
[177Lu- [DOTA0, Tyr3]-octreotate
Medical internal radiation dose
Patient-specific dosimetry
Online Access:http://link.springer.com/article/10.1186/s13550-018-0459-4

Internet

http://link.springer.com/article/10.1186/s13550-018-0459-4

Similar Items